DSS unit Impact Biomedical sets terms for downsized $6M IPO

Home » DSS unit Impact Biomedical sets terms for downsized $6M IPO
Businessman pointing hand on the transparent ipo text, trading, investment and business concept

DSS unit Impact Biomedical sets terms for downsized $6M IPO


Ingenious Buddy

Impact Biomedical (IBO), a subsidiary of DSS (NYSE:DSS), has disclosed updated terms for a downsized $6M initial public offering.

The company said in a recent SEC filing that it was now looking to offer 1.5M shares priced between $3 and $5, which would


Original article

Click here to view the original article

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on linkedin
LinkedIn
On Key

Related Posts

Wells Fargo shares tumble after net interest income falls short of estimates

Wells Fargo WFC Q2 2024 earnings

Wells Fargo on Friday reported a 9% decline in net interest income, even though its second-quarter earnings and revenue exceeded Wall Street expectations. Here’s what